Biovica International AB (BIOVIC_B) has successfully secured a SEK 2.5 million work order for its TKA testing, reinforcing its position in the diagnostic testing market.
Key Highlights:
- New Work Order Value: SEK 2.5 million.
- Total Value of Agreements: Three work orders now total SEK 7 million.
- Industry Impact: Strengthens Biovica’s presence in the advanced cancer diagnostics sector.
This latest deal further solidifies Biovica’s strategic expansion and commitment to providing innovative biomarker-based testing solutions.
